{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:51:10Z","timestamp":1791510670439,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.rdc.2026.08.003","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:52:57Z","timestamp":1791507177000},"page":"651-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Laryngeal Manifestations of Rheumatic Disease"],"prefix":"10.1016","volume":"52","author":[{"given":"Peter S.","family":"Giannaris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth E.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rdc.2026.08.003_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ph14030251","article-title":"Pharmacological interventions for pulmonary involvement in rheumatic diseases","volume":"14","author":"Kang","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.rdc.2026.08.003_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/lary.23551","article-title":"Intralesional steroid injection for benign vocal fold disorders: a systematic review and meta-analysis","volume":"123","author":"Wang","year":"2013","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.rdc.2026.08.003_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/lary.26151","article-title":"Systematic review for surgical treatment of adult and adolescent laryngotracheal stenosis","volume":"127","author":"Lewis","year":"2017","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.rdc.2026.08.003_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/00034894251408704","article-title":"Autoimmune disorders affecting the larynx: review of laryngoscopic findings and approach to multidisciplinary management","volume":"135","author":"Kotla","year":"2026","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"Suppl 8A","key":"10.1016\/j.rdc.2026.08.003_bib5","doi-asserted-by":"crossref","first-page":"113S","DOI":"10.1016\/S0002-9343(01)00856-7","article-title":"Inflammatory and granulomatous lesions of the larynx and pharynx","volume":"111","author":"Loehrl","year":"2001","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.rdc.2026.08.003_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-011-2214-2","article-title":"Bamboo nodes associated with mixed connective tissue disease as a cause of hoarseness","volume":"33","author":"Schwemmle","year":"2013","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.rdc.2026.08.003_bib7","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.rdc.2026.08.003_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092573","article-title":"Systematic review and metaanalysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis","volume":"11","author":"Redondo-Rodriguez","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib9","article-title":"Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis","volume":"6","author":"Ediboglu","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2026.08.003_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2021.07.037","article-title":"Presentation, diagnosis, and management of subglottic and tracheal stenosis during systemic inflammatory diseases","volume":"161","author":"Catano","year":"2022","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rdc.2026.08.003_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez217","article-title":"Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis","volume":"58","author":"Quinn","year":"2019","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.rdc.2026.08.003_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2018.05.005","article-title":"Frequency, treatment, evolution, and factors associated with the presence of tracheobronchial stenoses in granulomatosis with polyangiitis. Retrospective analysis of a case series from a single respiratory referral center","volume":"48","author":"Marroqu\u00edn-Fabi\u00e1n","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2026.08.003_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/lary.70249","article-title":"Immunosuppression and surgery-free interval in granulomatosis with polyangiitis airway stenosis","volume":"136","author":"Torres","year":"2026","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoto.2016.4131","article-title":"Endoscopic management of subglottic stenosis","volume":"143","author":"Feinstein","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"10","key":"10.1016\/j.rdc.2026.08.003_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kev129","article-title":"Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience","volume":"54","author":"Terrier","year":"2015","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.rdc.2026.08.003_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-021-05783-8","article-title":"Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis","volume":"40","author":"Jakes","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"22","key":"10.1016\/j.rdc.2026.08.003_bib17","article-title":"Early ear, nose and throat manifestations in eosinophilic granulomatosis with poliangioitis: results from our Cohort group and literature review","volume":"12","author":"D'Onofrio","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.rdc.2026.08.003_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103219","article-title":"Eosinophilic granulomatosis with polyangiitis: a review","volume":"22","author":"White","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.rdc.2026.08.003_bib19","doi-asserted-by":"crossref","DOI":"10.1017\/S0022215118000737","article-title":"Eosinophilic granulomatosis with polyangiitis and laryngeal involvement: review of the literature and a cross-sectional prospective experience","volume":"132","author":"Seccia V","year":"2018","journal-title":"J Laryngol Otol"},{"issue":"3","key":"10.1016\/j.rdc.2026.08.003_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/art.41982","article-title":"2022 American college of rheumatology\/European Alliance of associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"74","author":"Grayson","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2026.08.003_bib21","first-page":"202","article-title":"International consensus on antineutrophil cytoplasm antibodies testing in eosinophilic granulomatosis with polyangiitis","author":"Moiseev","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.rdc.2026.08.003_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"20","key":"10.1016\/j.rdc.2026.08.003_bib23","first-page":"376","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.rdc.2026.08.003_bib24","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2026.08.003_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/art.43398","article-title":"The effect of benralizumab and mepolizumab on use of oral glucocorticoids in patients with eosinophilic granulomatosis with polyangiitis","volume":"78","author":"Nair","year":"2026","journal-title":"Arthritis Rheumatol"},{"issue":"10416","key":"10.1016\/j.rdc.2026.08.003_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib27","doi-asserted-by":"crossref","DOI":"10.3109\/00016489109138441","article-title":"Laryngeal involvement in rheumatoid arthritis","volume":"111","author":"Geterud","year":"1991","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"10.1016\/j.rdc.2026.08.003_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvoice.2006.08.015","article-title":"Prevalence and relative risk of dysphonia in rheumatoid arthritis","volume":"22","author":"Speyer","year":"2008","journal-title":"J Voice"},{"issue":"4","key":"10.1016\/j.rdc.2026.08.003_bib29","article-title":"The diagnosis and treatment of rheumatoid and juvenile idiopathic arthritis of the temporomandibular joint","volume":"119","author":"Schmidt","year":"2022","journal-title":"Deutsches Arzteblatt international"},{"issue":"13","key":"10.1016\/j.rdc.2026.08.003_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.rdc.2026.08.003_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194587","article-title":"Radiological evaluation of cervical spine involvement in rheumatoid arthritis: a cross-sectional retrospective study","volume":"10","author":"Kotecki","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.rdc.2026.08.003_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2012.06.004","article-title":"Cricoarytenoid joint involvement in rheumatoid arthritis: radiologic evaluation","volume":"33","author":"Greco","year":"2012","journal-title":"Am J Otolaryngol"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib33","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-010-1657-2","article-title":"Three cases of rheumatoid arthritis with laryngeal stridor","volume":"30","author":"Peters","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2026.08.003_bib34","doi-asserted-by":"crossref","DOI":"10.1148\/radiology.158.2.3941873","article-title":"Cricoarytenoiditis: CT assessment in rheumatoid arthritis","volume":"158","author":"Brazeau-Lamontagne","year":"1986","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.rdc.2026.08.003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ard.2026.01.023","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update","volume":"85","author":"Smolen","year":"2026","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2026.08.003_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/ohn.616","article-title":"Management of bilateral vocal fold paralysis: a systematic review","volume":"170","author":"Lechien","year":"2024","journal-title":"Otolaryngology--head and neck surgery"},{"issue":"17","key":"10.1016\/j.rdc.2026.08.003_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus","author":"Siegel","year":"2024","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.rdc.2026.08.003_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/art.41632","article-title":"Prevalence of systemic lupus erythematosus in the United States: estimates from a meta-analysis of the centers for disease control and prevention national lupus registries","volume":"73","author":"Izmirly","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2026.08.003_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/0049-0172(92)90020-E","article-title":"Laryngeal involvement in systemic lupus erythematosus","volume":"22","author":"Teitel","year":"1992","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2026.08.003_bib40","article-title":"Systemic lupus erythematosus-related lung disease","volume":"45","author":"Bendstrup","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.rdc.2026.08.003_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/art.40930","article-title":"2019 european League against Rheumatism\/American College of Rheumatology Classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2026.08.003_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2026.08.003_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/lary.25112","article-title":"Voice disorders in Sj\u00f6gren\u2019s syndrome: prevalence and related risk factors","volume":"125","author":"Pierce","year":"2015","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.rdc.2026.08.003_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.10.011","article-title":"Consensus guidelines for evaluation and management of pulmonary disease in Sj\u00f6gren\u2019s","volume":"159","author":"Lee","year":"2020","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.rdc.2026.08.003_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/0003489414538762","article-title":"Voice, speech, and laryngeal features of primary Sj\u00f6gren\u2019s syndrome","volume":"123","author":"Heller","year":"2014","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"10","key":"10.1016\/j.rdc.2026.08.003_bib46","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary Sj\u00f6gren\u2019s syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.rdc.2026.08.003_bib47","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.rdc.2026.08.003_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s00455-009-9235-y","article-title":"Oropharyngolaryngeal disorders in scleroderma: development and validation of the SLS scale","volume":"25","author":"Vitali","year":"2010","journal-title":"Dysphagia"},{"issue":"10373","key":"10.1016\/j.rdc.2026.08.003_bib49","first-page":"401","article-title":"Systemic sclerosis","author":"Volkmann","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"7","key":"10.1016\/j.rdc.2026.08.003_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/apt.13963","article-title":"Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis","volume":"45","author":"Kumar","year":"2017","journal-title":"Aliment Pharmacol Therapeut"},{"issue":"1","key":"10.1016\/j.rdc.2026.08.003_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/art.41933","article-title":"Systemic sclerosis-associated interstitial lung disease: how to incorporate two food and drug administration-approved therapies in clinical practice","volume":"74","author":"Khanna","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"15","key":"10.1016\/j.rdc.2026.08.003_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154631","article-title":"New era in systemic sclerosis treatment: recently approved therapeutics","volume":"11","author":"Ebata","year":"2022","journal-title":"J Clin Med"},{"issue":"9923","key":"10.1016\/j.rdc.2026.08.003_bib53","first-page":"383","article-title":"Sarcoidosis","author":"Valeyre","year":"2014","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/coa.13814","article-title":"Sarcoidosis of the ear, nose and throat: a review of the literature","volume":"46","author":"Cereceda-Monteoliva","year":"2021","journal-title":"Clin Otolaryngol"},{"issue":"6","key":"10.1016\/j.rdc.2026.08.003_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2025.104725","article-title":"Laryngeal sarcoid: clinical presentation, management, and outcomes at a tertiary care center","volume":"46","author":"Pai","year":"2025","journal-title":"Am J Otolaryngol"},{"issue":"4","key":"10.1016\/j.rdc.2026.08.003_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/ohn.70129","article-title":"Diagnosis and management of isolated laryngeal sarcoidosis: a systematic review","volume":"174","author":"Malhotra","year":"2026","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.rdc.2026.08.003_bib57","doi-asserted-by":"crossref","DOI":"10.1007\/s00234-022-02922-z","article-title":"Comprehensive radiological features of laryngeal sarcoidosis: cases series and systematic review","volume":"64","author":"Baba","year":"2022","journal-title":"Neuroradiology"},{"issue":"7","key":"10.1016\/j.rdc.2026.08.003_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/000348949510400705","article-title":"Laryngoscopic diagnosis of laryngeal sarcoid","volume":"104","author":"Benjamin","year":"1995","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"2","key":"10.1016\/j.rdc.2026.08.003_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjms.2018.11.007","article-title":"Sinonasal and laryngeal Sarcoidosis-An uncommon presentation and management challenge","volume":"357","author":"Edriss","year":"2019","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.rdc.2026.08.003_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(17)30471-4","article-title":"IgG4-related disease of the central and peripheral nervous systems","volume":"17","author":"AbdelRazek","year":"2018","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.rdc.2026.08.003_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(24)00089-4","article-title":"Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology-European League against Rheumatism classification criteria","volume":"6","author":"Jha","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2026.08.003_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/art.41120","article-title":"The 2019 American college of Rheumatology\/European League against rheumatism classification criteria for IgG4-Related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2026.08.003_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: data from a French nationwide study of thirty-three patients","volume":"12","author":"Ebbo","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.rdc.2026.08.003_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.rdc.2026.08.003_bib65","first-page":"392","article-title":"Inebilizumab for treatment of IgG4-Related disease","author":"Stone","year":"2025","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.rdc.2026.08.003_bib66","article-title":"Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study","volume":"54","author":"Hazra","year":"2015","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.rdc.2026.08.003_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/art.39790","article-title":"Relapsing polychondritis can be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients","volume":"68","author":"Dion","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2026.08.003_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/art.41270","article-title":"Defining clinical subgroups in relapsing polychondritis: a prospective observational cohort study","volume":"72","author":"Ferrada","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2026.08.003_bib69","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kex406","article-title":"Relapsing polychondritis: a clinical review for rheumatologists","volume":"57","author":"Kingdon","year":"2018","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.rdc.2026.08.003_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103352","article-title":"Relapsing polychondritis - a single centre study in the United Kingdom","volume":"22","author":"Sangle","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.rdc.2026.08.003_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-04493-0","article-title":"Nationwide cross-sectional survey of patients with relapsing polychondritis in 2019 demonstrates reduction of airway involvement compared with that in 2009","volume":"12","author":"Shimizu","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.55563\/clinexprheumatol\/h9gq1o","article-title":"Treatment of relapsing polychondritis: a systematic review","volume":"40 Suppl 134","author":"Petitdemange","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2026.08.003_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-35616-4","article-title":"Evaluation of airway involvement and treatment in patients with relapsing polychondritis","volume":"13","author":"Handa","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.rdc.2026.08.003_bib74","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2010.1977","article-title":"Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies","volume":"305","author":"Rider","year":"2011","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.rdc.2026.08.003_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(25)00233-9","article-title":"Advances in the classification and management of idiopathic inflammatory myopathies","volume":"24","author":"Raaphorst","year":"2025","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.rdc.2026.08.003_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072150","article-title":"The impact of dysphagia in myositis: a systematic review and meta-analysis","volume":"9","author":"Labeit","year":"2020","journal-title":"J Clin Med"},{"issue":"14","key":"10.1016\/j.rdc.2026.08.003_bib77","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2117912","article-title":"Trial of intravenous immune globulin in dermatomyositis","volume":"387","author":"Aggarwal","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rdc.2026.08.003_bib78","first-page":"13","article-title":"Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis","author":"Zhen","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/art.41602","article-title":"Study of tofacitinib in refractory dermatomyositis: an open-label pilot study of ten patients","volume":"73","author":"Paik","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"10431","key":"10.1016\/j.rdc.2026.08.003_bib80","first-page":"403","article-title":"Beh\u00e7et\u2019s syndrome","author":"Emmi","year":"2024","journal-title":"Lancet (London, England)"},{"issue":"7","key":"10.1016\/j.rdc.2026.08.003_bib81","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra2305712","article-title":"Beh\u00e7et\u2019s syndrome","volume":"390","author":"Saadoun","year":"2024","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.rdc.2026.08.003_bib82","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020221","article-title":"Vocal cord involvement and hoarseness in a patient with Behcets disease: a rare case report","volume":"99","author":"Zhou","year":"2020","journal-title":"Medicine"},{"issue":"10201","key":"10.1016\/j.rdc.2026.08.003_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2009.10.009","article-title":"Geoepidemiologic considerations of auto-immune pemphigus","volume":"9","author":"Meyer","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.rdc.2026.08.003_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2011.06.022","article-title":"Mucosal manifestations of pemphigus vulgaris in ear, nose, and throat; before and after treatment","volume":"67","author":"Robati","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.rdc.2026.08.003_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-3083.2011.03981.x","article-title":"Ear, nose and throat involvement in patients with pemphigus vulgaris: correlation with severity, phenotype and disease activity","volume":"25","author":"Kavala","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.rdc.2026.08.003_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/lary.31448","article-title":"Characteristic laryngeal findings in patients with Pemphigus vulgaris","volume":"134","author":"Hosoya","year":"2024","journal-title":"Laryngoscope"},{"issue":"10083","key":"10.1016\/j.rdc.2026.08.003_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"9275","key":"10.1016\/j.rdc.2026.08.003_bib89","first-page":"358","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","author":"Gillmore","year":"2001","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.rdc.2026.08.003_bib90","doi-asserted-by":"crossref","first-page":"152762","DOI":"10.1016\/j.semarthrit.2025.152762","article-title":"AA amyloidosis in inflammatory joint diseases: a systematic review","volume":"74","author":"Savadogo","year":"2025","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2022.103550","article-title":"Localized laryngeal amyloidosis: a systematic review","volume":"43","author":"Pai","year":"2022","journal-title":"Am J Otolaryngol"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/modpathol.3880092","article-title":"Amyloidosis of the larynx: a clinicopathologic study of 11 cases","volume":"13","author":"Thompson","year":"2000","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.rdc.2026.08.003_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040136","article-title":"Rituximab therapy in renal amyloidosis secondary to rheumatoid arthritis","volume":"8","author":"Kilic","year":"2018","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.rdc.2026.08.003_bib94","doi-asserted-by":"crossref","DOI":"10.1080\/00016489.2019.1680864","article-title":"Curative effect of cold micro forceps and CO2 laser in the treatment of laryngeal amyloidosis","volume":"139","author":"Wu","year":"2019","journal-title":"Acta Otolaryngol"},{"issue":"10473","key":"10.1016\/j.rdc.2026.08.003_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(24)02263-3","article-title":"Axial spondyloarthritis","volume":"405","author":"Navarro-Comp\u00e1n","year":"2025","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.rdc.2026.08.003_bib96","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.20917","article-title":"Review: axial spondyloarthritis","volume":"333","author":"Bittar","year":"2025","journal-title":"JAMA"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X2600058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X2600058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:27:26Z","timestamp":1791509246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X2600058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0889857X2600058X"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2026.08.003","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laryngeal Manifestations of Rheumatic Disease","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2026.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}